Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001

M P Coleman, B Rachet, L M Woods, E Mitry, M Riga, N Cooper, M J Quinn, H Brenner, J Estève, M P Coleman, B Rachet, L M Woods, E Mitry, M Riga, N Cooper, M J Quinn, H Brenner, J Estève

Abstract

We examined national trends and socioeconomic inequalities in cancer survival in England and Wales during the 1990s, using population-based data on 2.2 million patients who were diagnosed with one of the 20 most common cancers between 1986 and 1999 and followed up to 2001. Patients were assigned to one of five deprivation categories (from 'affluent' to 'deprived') using characteristics of their electoral ward of residence at diagnosis. We estimated relative survival up to 5 years after diagnosis, adjusting separately in each deprivation category for background mortality by age, sex and calendar period. We estimated trends in survival and in the difference in survival between deprivation categories ('deprivation gap') over the periods 1986-90, 1991-95 and 1996-99. We used period analysis to examine likely survival rates in the near future. Survival improved for most cancers in both sexes during the 1990s, and appears likely to continue improving for most cancers in the near future. The deprivation gap in survival between rich and poor was wider for patients diagnosed in the late 1990s than in the late 1980s. Increases in cancer survival in England and Wales during the 1990s are shown to be significantly associated with a widening deprivation gap in survival.

Figures

Figure 1
Figure 1
Relative survival up to 5 years, by calendar period of diagnosis, England and Wales, men with cancer of the rectum diagnosed 1986–99 and followed up to 2001. The dashed curve is derived from period analysis using survival experience during 2000–01.
Figure 2
Figure 2
Five year relative survival (%) by deprivation category and calendar period of diagnosis, England and Wales, men with cancer of the rectum diagnosed in successive calendar periods 1986–99 and followed up to 2001.
Figure 3
Figure 3
Average change every 5 years in relative survival (%) and in the deprivation gap in survival (%): England and Wales, 1- and 5-year survival, selected cancers, men and women diagnosed during the period 1986–99 and followed up to 2001. Prostate cancer was excluded from the regression and the scatter-plot (see text).

References

    1. Berkson J, Gage RP (1950) Calculation of survival rates for cancer. Proc Staff Meet Mayo Clinic 25: 270–286
    1. Brenner H, Gefeller O (1996) An alternative approach to monitoring cancer patient survival. Cancer 78: 2004–2010
    1. Carstairs V (1995) Deprivation indices: their interpretation and use in relation to health. J Epidemiol Common Health 49: s3–s8
    1. Coleman MP, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, Knerer G, Pitard A, Quinn MJ, Sloggett A, De Stavola BL (1999) Cancer Survival Trends in England and Wales 1971–1995: Deprivation and NHS Region, Series SMPS No. 61. London: The Stationery Office
    1. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani M, Berrino F, EUROCARE Working Group (2003) EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14: 128v–149
    1. Department of Health (1999) Saving Lives: Our Healthier Nation. London: Department of Health
    1. Department of Health (2000) The NHS Cancer Plan. London: Department of Health
    1. Department of Health (2003a) Tackling Health Inequalities: A Programme for Action. London: Department of Health
    1. Department of Health (2003b) The NHS Cancer Plan: Three-year Progress Report – Maintaining the Momentum. London: Department of Health
    1. Department of the Environment Transport and the Regions (2000) Measuring Multiple Deprivation at the Small Area Level: The Indices of Deprivation 2000. London: DETR
    1. Dixon A, Henderson J, Murray R, Poteliakhoff E (2003) Is the NHS Equitable? A Review of the Evidence. LSE Health and Social Care Discussion Paper Number 11. London: London School of Economics
    1. Estève J, Benhamou E, Croasdale M, Raymond L (1990) Relative survival and the estimation of net survival: elements for further discussion. Stat Med 9: 529–538
    1. Evans HS, Møller H (2003) Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol 43: 337–341
    1. Expert Advisory Group on Cancer (1995) A Policy Framework for Commissioning Cancer Services. London: Department of Health
    1. Grizzle JE, Starmer CF, Koch GG (1969) Analysis of categorical data by linear models. Biometrics 25: 489–504
    1. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds) (1991) Cancer Registration: Principles and Methods. IARC Scientific Publications No. 95. Lyon: International Agency for Research on Cancer
    1. Lyratzopoulos G, West CR, Williams EMI (2003) Socioeconomic variation in colon cancer tumour factors associated with poorer prognosis. Br J Cancer, (in press).
    1. McArdle CS, Hole DJ (2002) Outcome following surgery for colorectal cancer. Br Med Bull 64: 119–125
    1. Mitry E, Bouvier A-M, Estève J, Faivre J (2002) Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg 89: 1557–1562
    1. National Assembly for Wales (2000) Welsh Index of Multiple Deprivation. Cardiff: National Assembly for Wales
    1. NCEPOD (2001) Changing the Way we Operate: The 2001 Report of the National Confidential Enquiry into Perioperative Deaths. London: National Confidential Enquiry into Perioperative Deaths
    1. NHS Executive (1997) The New NHS. Modern. Dependable. London: Department of Health
    1. Office for National Statistics (1991) 1991 Census: small area statistics and local base statistics [computer file]. ESRC/JISC Census Programme, Census Dissemination Unit, University of Manchester
    1. Office for National Statistics (2003a) Cancer Statistics: Registrations of Cancer diagnosed in 2000, England. Series MB1 no. 31. London: The Stationery Office
    1. Office for National Statistics (2003b) Census 2001 homepage. ONS, , accessed 11 March 2003.
    1. Penhale B, Noble M (2000) Ward level Population Estimates mid-1998. Social Disadvantage Research Group, Department of Policy and Social Work, University of Oxford: Oxford
    1. Quinn MJ, Babb P, Brock A, Kirby L, Jones J (2001) Cancer trends in England and Wales 1950-1999. Studies on Medical and Population Subjects No. 66. London: Office for National Statistics
    1. Rabeneck L, Souchek J, El-Serag HB (2003) Survival of colorectal cancer patients hospitalized in the Veterans Affairs health care system. Am J Gastroenterol 98: 1186–1192
    1. Richards MA, Smith P, Ramirez AJ, Fentiman I, Rubens RD (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79: 858–864
    1. Schrijvers CTM, Mackenbach J, Lutz J-M, Quinn MJ, Coleman MP (1995) Deprivation, stage at diagnosis and cancer survival. Int J Cancer 63: 324–329
    1. StataCorp. STATA statistical software. [5.0]. 1997. Stata Corporation: College Station, TX
    1. Stockton D, Davies TW, Day NE, McCann J (1997) Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: earlier diagnosis or better treatment? Br Med J 314: 472–475

Source: PubMed

3
订阅